The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Multiplatform molecular profiling of 2,400 pancreatic adenocarcinomas to identify targets for therapeutic intent.
Sherri Z. Millis
Employment or Leadership Position - Caris Life Sciences
David Arguello
Employment or Leadership Position - Caris Life Sciences
Maeve Aine Lowery
No relevant relationships to disclose
Eileen Mary O'Reilly
No relevant relationships to disclose